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Objectives: The aim of the present study was to determine the Chlamydia trachomatis preva-
lence  and to identify the demographic, behavioural and clinical factors associated with C.
trachomatis  in human immunodeﬁciency virus infected men.
Study:  This was a cross-sectional study of C. trachomatis prevalence among human
immunodeﬁciency virus-infected men enrolled at the Outpatient clinic of acquired immu-
nodeﬁciency  syndrome of the Fundac¸ão  de Medicina Tropical Dr. Heitor Vieira Dourado in
Manaus,  Amazonas, Brazil. C. trachomatis deoxyribonucleic acid from urethral samples was
puriﬁed and submitted to real time polymerase chain reaction to identify the presence of C.
trachomatis.
Results: A total of 276 human immunodeﬁciency virus-infected men  were included in
the  study. The prevalence of C. trachomatis infection was 12% (95% conﬁdence interval
8.1%–15.7%).  The mean age of the participants was 34.63 (standard deviation 10.80) years. Of
the 276 human immunodeﬁciency virus-infected men, 93 (56.2%) had more  than one sexual
partner  in the past year and 105 (38.0%) reported having their ﬁrst sexual intercourse under
the  age of 15 years. Men having sex with men and bisexuals amounted to 61.2% of the stud-
ied population. A total of 71.7% had received human immunodeﬁciency virus diagnosis in
the  last three years and 55.1% were using antiretroviral therapy. Factors associated with C.
trachomatis infection in the logistic model were being single (p < 0.034), men having sex with
men  (p < 0.021), and having previous sexually transmitted diseases (p < 0.001).
Conclusion: The high prevalence of C. trachomatis infection among human immunodeﬁciencyvirus-infected men highli
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ntroduction
enital Chlamydia trachomatis (CT) infection, the most preva-
ent  sexually transmitted disease (STDs) in the world, is a
ajor  public health problem.1,2 Asymptomatic infections are
ommon  and are associated with high probability of acquir-
ng  human immunodeﬁciency virus (HIV) infection.3–5 The
creening  of HIV-infected individuals for CT is a key strategy
or  reducing the transmission of HIV.2,3 Few studies have been
onducted  on CT infection among men  in Brazil.6 A study in
IV-negative  men  attending STDs clinics have estimated the
ncidence  of urethral CT infection to be 13.1%.7 Studies con-
ucted  in HIV-infected men  outside of Brazil have reported
revalence rates of 9%8 and 2–10% in HIV-infected men  and in
en  who have sex with men  (MSM),2,9 respectively.
There is no mandatory reporting system for CT infec-
ions  in Brazil,8 and the lack of population-based studies
n  HIV-infected patients hinders efforts to document the
roblem,  implement priority interventions and evaluate their
fﬁcacy. Screening for CT infection in HIV-infected individ-
als  is important for monitoring STDs and for elaborating
reventive measures as well as treatment assistance to this
opulation.
The  present study aimed to determine the prevalence of
T  infection and associated risk factors in HIV-infected men
ollowed  in a referral hospital specializing in infectious and
ropical  diseases in Manaus, Amazonas, Brazil.
ethods
 population based cross-sectional study among HIV-infected
en  was  conducted at the referral hospital of the Fundac¸ão
e  Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD)
n  Manaus, capital city of the state of the Amazonas, Brazil
rom  November 1, 2009 to November 1, 2010. HIV-infected
en  were  invited to participate in the study by signing an
nformed  consent form as approved by the ethical committee
f  the FMT-HVD. Each participant answered a questionnaire
oncerning socio-demographic factors, age of ﬁrst sexual
ntercourse, number of sexual partners over the past 12
onths,  regular use of condoms, sexual behaviours, prior
ymptoms  of STDs. Signs and symptoms of STD on physical
xamination were  also recorded and adequate treatment was
rovided.
The  inclusion criteria were the following: male individuals
ith  positive serology for HIV 1–2, sexually active, over 18
ears  of age and agreed to a urethral sample collection. Vul-
erable  male patients (mental diseases and younger than 18
ears  old) were  excluded from the study.
The sample size was  calculated for estimating the
revalence of CT infection in Human immunodeﬁciency
irus/acquired immunodeﬁciency syndrome (HIV/AIDS) peo-
le with a 95% conﬁdence interval (CI) and a bilateral size of
.5%.  The sample size was  calculated based on an average rate
f 6.0% with a variation of ±3.0% which generated a number
f  270 patients. Assuming a loss of 10%, the ﬁnal sample size
as  297 patients. Of note, the FMT-HVD is the referral cen-
re  for AIDS and all the patients with HIV/AIDS from the state4;1 8(2):158–163  159
of Amazonas are referred to that centre. An average of 310
HIV-infected men  is treated yearly from 2001 to 2010 at the
FMT-HVD  and in the year 2010, a total of 530 HIV-infected men
were  enrolled.
Urethral samples were collected by inserting a small
brush (Cavi-brush) in the distal urethra, between 1.5 and
2  cm,  and rotating it ﬁve times clockwise. The samples were
then  placed in tubes containing 400 L of buffer solution
(10  mM Tris–HCL and 1 mM EDTA) and kept on ice until they
were  transported to the laboratory, where they were stored
at  −20 ◦C until processing for deoxyribonucleic acid (DNA)
puriﬁcation. DNA puriﬁcation was  performed using the com-
mercial  DNA extraction kit Nucleo-Spin Tissue – Machery –
NagelTM following the company’s instructions. For the detec-
tion  of CT DNA by RT-PCR, the following pair of primers
amplifying a fragment of 241 base pairs CT plasmid DNA
was  used: KL1 5′-TCCGGAGCGAGTTACGAAGA-3′ and KL 2′-
AATCAATGCCCGGGATTGGT-3′. Brieﬂy, 5 L of DNA sample
and  3 L of each primer (10 pmol/L) were  added to a ﬁnal vol-
ume  of 25 L containing 12.5 L of Maxima® SYBR Green/ROX
qPCR Master Mix  (2×). For the initial conﬁrmation of the ampli-
con  size the PCR product was electrophoresed in 1.5% agarose
gel  and revealed with ethidium bromide under UV. Further-
more,  sample was  considered positive when RT-PCR analysis
showed  unique peak dissociation curve at 78 ◦C.
The data were  stored and analyzed using the Epi Info
software, version 3.5.2, and the Statistical Package for Social
Science  (SPSS) version 16.0 for Windows. Chi-square test with
Yates  correction was  used to assess for possible associations
between clinical, demographic or risk behaviours variables
and  CT infection. Fisher exact test was  applied when appro-
priate.  The odds ratio along with the 95% conﬁdence interval
(95%  CI) was calculated for variables to estimate the degree of
association  between CT infection and potential risk factors.
The  multivariate logistic regression analysis was  applied to
examine  the independent effect of each demographic, clin-
ical  or risk behaviour variables on CT infection, controlling
for  all other variables simultaneously. All variables that were
moderately  associated with a signiﬁcance of p ≤ 0.15 in the
univariate  analysis were  considered for inclusion in the multi-
variate  model. In the ﬁnal model analysis, only those variables
that  remained signiﬁcant with p < 0.05 were considered.
Results
Of a total of 276 HIV-infected men  included in the study, 33
were  infected with CT infection showing a prevalence of 12%
(95%  CI 8.1%–15.7%). No urethral symptoms were  observed in
any  of the HIV-infected men. Baseline characteristics of the
participants  are shown in Table 1. The mean age of partici-
pants  was 34.6 years (SD = 10.8) and 36.6% were 29 years old or
less. More than 80% of the 276 HIV-infected men  had up to 11
years  of schooling. A total of 63.8% reported alcohol use and
23.9%  illicit drugs abuse.
Concerning  risk behaviours, as shown in Table 2, 93
(56.2%) participants reported having more  than one sexual
partner  in the past year, and 105 (38.0%) had their ﬁrst sexual
intercourse under the age of 15 years. Prior to the diagnosis
of  HIV infection, 230 (83.3%) patients admitted irregular use
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Table 1 – Prevalence of CT infection (RT-PCR) and its association with socio-demographic factors among 276 HIV-infected
men treated at the FMT-HVD, 2009–2010.
Demographic Indices n (%) CT positive CT negative p-Value
Age
18–29 years 101 (36.6) 2 22 0.3785a
30–49 years 151 (54.7) 17 134
≥50 years 24 (8.7) 2 22
Race/colour
Mulatto 210 (76.1) 21  189 0.066a
White 48 (17.4) 11 37
Black 18 (6.5) 1 17
Marital status
Single  158 (57.2) 25 133 0.034a
Married/Living together 109 (39.5) 8 101
Divorced 7 (2.5) 0 7
Widower 2 (0.8) 0 2
Education
Primary 97 (35.1) 11 86 0.111a
Secondary 125 (45.3) 11 114
College 52 (18.8) 11 41
Illiterate 2 (0.8) 0  2
Alcohol consumption
Yes  176 (63.8) 24 152 0.335b
No 100 (36.2) 9 91
Use of illicit drugs
Yes  66 (23.9) 12 54 0.0837b
No 210 (76.1) 21 189a Pearson’s chi-squared test (considered signiﬁcant when p ≤ 0.05).
b Extended Fisher’s exact test (considered signiﬁcant when p ≤ 0.05).
of condoms. After the diagnosis, 206 (74.6%) reported always
using  condoms. However, 179 (64.9%) subjects reported having
previous  STDs. A history of STDs was  strongly associated
(p  < 0.001) with the detection of CT. Regarding sexual orienta-
tion,  homosexuals and bisexuals together made up to 61.2%
of  the studied population. Multivariate logistic regression
showed that MSM  [OR = 2.51 (95% CI 1.12–6.64) and previous
STD  [OR = 3.46 (95% CI 1.96–5.72) were  independent risk
factors  for CT infection among HIV-infected men.
Table 3 shows variables related to HIV status. None of the
variables  studied showed any association with CT infection. A
total of 71.7% had received the HIV diagnosis in the last three
years  and 55.1% were  using antiretroviral therapy.
Discussion
Our study prospectively investigated CT infection among HIV-
infected men  in the Amazonas through the RT-PCR technology
to  provide a rapid diagnosis for improving management of
patients  so as to limit the spread of CT. In Brazil, limited data
are  available demonstrating the precise pattern of the epi-
demiological behaviour of CT infection in men,6,10 and the
status  of this infection within the population of HIV-infected
men  is unknown.
The  prevalence of CT urethral infection in HIV-infected
men  observed in this study was  12%. The observed prevalence
is  similar to that observed in non-HIV-infected men  receivingcare  at six STD clinics in Brazil,6 and in HIV-infected men  in
United  Kingdom and USA.8,11
STDs are of primary importance because of the emergence
of  AIDS. These infections enhance the sexual transmission
of  HIV3,12,13 and are associated with earlier and more  severe
symptoms in HIV-infected individuals.14–16 Furthermore, they
can  cause serious complications, resulting in chronic diseases
and  even death. Infections in men  often cause problems in
the  genitourinary tract that can result in male infertility. In
women,  the consequences can be extremely severe, including
chronic  pelvic pain, infertility, and cervical cancer.16,17
None of the HIV-infected men  with CT infection in
this  study showed any urethral symptoms, which is con-
sistent  with most previous studies. A high proportion of
asymptomatic patients has been observed in CT infections18
indicating a need for screening in this population.11,19–21 The
routine  testing of patients remains a controversial issue, given
that  some studies show a higher prevalence of CT infection
among individuals with urethral symptoms.8,19,22–24
Several studies have reported higher prevalence of CT
infection in young individuals (<25 years of age),23 but it
was  not observed in this study. Similar to work previously
published by Iwuji et al. in 2008 in the United Kingdom,8
other studies have reported common associations between
CT  infections and reports of multiple partners, irregular use
25,26of  condoms and a history of STDs. Here, only a history of
STDs  was found to be associated with CT infection. Notably,
Fioravante et al.25 observed a prevalence of 5% of chlamy-
dial  infection among male asymptomatic conscripts. This may
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Table 2 – Sexual behaviours of 276 patients with HIV+/AIDS sorted by CT urethral infection status as detected by PCR.
Variables n (%) CT positive CT negative p-Value
Onset of sexual activity
≤15  years 105 (38.0) 7 98 0.078a
15–19 years 151 (54.7) 22 129
≥20 years 20 (7.3) 4 16
No. of sexual partners in the past year
None  24 (8.7) 3 21 0.068a
1 97 (35.1) 5 92
2–9 93 (33.7) 14 79
≥10 62 (22.5) 11 51
Use of condoms before HIV+ diagnosis
Sometimes  230 (83.3) 32 198 0.091a
Always 7 (2.5) 0 7
Never 39 (14.2) 1 38
Use of condoms after HIV+ diagnosis
No  sex 34 (12.4) 5  29 0.766a
Sometimes 29 (10.5) 4  25
Always 206 (74.6) 24 182
Never 7 (2.5) 0 7
Sexual orientation
MSMb 101 (36.6) 14 87 0.021a
Bisexual 68 (24.6) 13 55
Heterosexual 107 (38.8) 6 101
Previous STDs
Yes  179 (64.9) 30 149 0.001a
No 97 (35.1) 3 94a Pearson’s chi-squared test (considered signiﬁcant when p ≤ 0.05).
b Men who have sex with men.
Table 3 – Variables associated with the presence of HIV among 
detected by PCR.
Variables n (%) CT po
Time since HIV diagnosisa
≤3 years 198 (71.7) 23 
4–6 years 38 (13.8) 6 
7–9 years 15 (5.4) 0 
≥10 years 25 (9.1) 4 
Use of ARTb
Yes 152 (55.1) 25 
No 124 (44.9) 8 
Period receiving ARTb
<1 year 79 (52.0) 25 
1–2 years 16  (10.5) 0 
2–3 years 12 (7.9) 0 
>3 years 45 (29.6) 8 
TCD4 Lymphocyte count (cells/mm3)
<200 103 (37.3) 13 
200–349 68 (24.6) 10 
350–500 41 (14.9) 4 
>500 40 (14.5) 6 
No results available 24 (8.7) 0 
a Related to all 276 participants in the study.
b Related to 152 patients who received antiretroviral therapy (ART).
c Pearson’s chi-squared test (considered signiﬁcant when p ≤ 0.05).
d Extended Fisher’s exact test (considered signiﬁcant when p ≤ 0.05).276 patients sorted by CT urethral infection status as
sitive CT negative p-Value
179 0.330c
28
15
21
127 0.5778d
116
54 0.509c
16
12
37
90 0.310d
58
37
34
24
i s . 2 0
r
1
1
1
1
1
1
1
1
1
1
2
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reﬂect the prevalence in the general population of male Brazil-
ians,  which is lower than the prevalence in HIV-infected men.
A  signiﬁcant association between CT urethral infection
and  sexual orientation (MSM)  was  noted in this study. Sev-
eral  studies have demonstrated that a high prevalence of
STDs,9,27 bacterial STDs,14 anorectal CT,22–24,28 and CT urethral
infection14,28 are directly related to the sexual behaviour of
MSM.
The  possibility of response bias may  be a limitation in
this  study due to the tendency to provide socially acceptable
answers. However, such biases would result in underestima-
tion  of risk attitudes and behaviours. Inaccuracies of recall
of  condom use, age of ﬁrst intercourse, and number of sex-
ual  partners may  also have occurred. Another limitation
is  probably few HIV-infected individuals coming from high
socioeconomic classes who  may  seek private clinics for treat-
ment  and thus potentially introducing patient selection bias.
However,  as treatment delivered for free in public hospitals
in  Brazil compared to the expensive cost in private hospitals,
selection bias may  have been negligible.
The ﬁndings from this study have important implications
for  education and prevention efforts directed towards young
HIV-infected men, mainly MSM.  A comprehensive approach
would  promote sexual responsibility and, at the same time,
improve  young men’s understanding of sexual health risks to
curb the spread of CT infection.
The  lack of clinical symptoms in CT infection impairs the
identiﬁcation of infected individuals. This study underscores
the  need for screening through laboratorial tests to identify
these  individuals for rapid treatment, to limit the spread and
also  to avoid chronic symptoms and severe consequences for
the individual. This topic is of extreme importance for health
policies,  as it has a signiﬁcant impact on family policy and
has  consequences for the sexual and reproductive health of
both  the population in general and, more  speciﬁcally, the HIV-
infected  population.
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